recombinant-plasma-protein-therapeutics-market

Recombinant Plasma Protein Therapeutics Market By Drug Class (Recombinant Factor VIII and Recombinant Factor IX), By Cell Line (Chinese Hamster Ovary, Baby Hamster Kidney and Human Embryonic Kidney and Other), By Indication (Hemophilia A, Hemophilia B, Von Willebrand Disease and Other) - Growth, Future Prospects & Competitive Analysis, 2024 – 2032

18 Apr 2019 Format PDF icon PPT icon XLS icon Request Sample
Choose Licence Type
$4500
$6500
$9000
Why Acute
View Other Reports